Milestone
Portfolio company Variational AI entered collaboration with Merck to discover novel small molecule therapeutics using its Enki AI platform. Total potential deal value up to USD $349 million.
Variational AI
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Variational AI
Zyphra
Foundation
Nexera
Zyphra
Nexera
Ranger AI
Mythic
Variational AI